These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 8683152

  • 1. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
    Staats HF, Nichols WG, Palker TJ.
    J Immunol; 1996 Jul 01; 157(1):462-72. PubMed ID: 8683152
    [Abstract] [Full Text] [Related]

  • 2. Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target.
    Manocha M, Pal PC, Chitralekha KT, Thomas BE, Tripathi V, Gupta SD, Paranjape R, Kulkarni S, Rao DN.
    Vaccine; 2005 Dec 01; 23(48-49):5599-617. PubMed ID: 16099080
    [Abstract] [Full Text] [Related]

  • 3. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
    Porgador A, Staats HF, Faiola B, Gilboa E, Palker TJ.
    J Immunol; 1997 Jan 15; 158(2):834-41. PubMed ID: 8993001
    [Abstract] [Full Text] [Related]

  • 4. Intranasal immunization is superior to vaginal, gastric, or rectal immunization for the induction of systemic and mucosal anti-HIV antibody responses.
    Staats HF, Montgomery SP, Palker TJ.
    AIDS Res Hum Retroviruses; 1997 Jul 20; 13(11):945-52. PubMed ID: 9223410
    [Abstract] [Full Text] [Related]

  • 5. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation.
    Buonaguro L, Visciano ML, Tornesello ML, Tagliamonte M, Biryahwaho B, Buonaguro FM.
    J Virol; 2005 Jun 20; 79(11):7059-67. PubMed ID: 15890945
    [Abstract] [Full Text] [Related]

  • 6. Mucosal immunization with inactivated HIV-1-capturing nanospheres induces a significant HIV-1-specific vaginal antibody response in mice.
    Akagi T, Kawamura M, Ueno M, Hiraishi K, Adachi M, Serizawa T, Akashi M, Baba M.
    J Med Virol; 2003 Feb 20; 69(2):163-72. PubMed ID: 12683403
    [Abstract] [Full Text] [Related]

  • 7. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate.
    Matoba N, Geyer BC, Kilbourne J, Alfsen A, Bomsel M, Mor TS.
    Vaccine; 2006 Jun 05; 24(23):5047-55. PubMed ID: 16621185
    [Abstract] [Full Text] [Related]

  • 8. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens.
    Okada E, Sasaki S, Ishii N, Aoki I, Yasuda T, Nishioka K, Fukushima J, Miyazaki J, Wahren B, Okuda K.
    J Immunol; 1997 Oct 01; 159(7):3638-47. PubMed ID: 9317164
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of intranasal with targeted lymph node immunization using PR8-Flu ISCOM adjuvanted HIV antigens in macaques.
    Koopman G, Bogers WM, van Gils M, Koornstra W, Barnett S, Morein B, Lehner T, Heeney JL.
    J Med Virol; 2007 May 01; 79(5):474-82. PubMed ID: 17385685
    [Abstract] [Full Text] [Related]

  • 16. Mucosal and systemic adjuvant effects of cholera toxin and Cry1Ac protoxin on the specific antibody response to HIV-1 C4/V3 peptides are different and depend on the antigen co-administered.
    Esquivel-Pérez R, Moreno-Fierros L.
    Viral Immunol; 2005 May 01; 18(4):695-708. PubMed ID: 16359236
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.
    Sakaue G, Hiroi T, Nakagawa Y, Someya K, Iwatani K, Sawa Y, Takahashi H, Honda M, Kunisawa J, Kiyono H.
    J Immunol; 2003 Jan 01; 170(1):495-502. PubMed ID: 12496436
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.